UP!

CYOU $10.74

CYOU target price
10.74
0
0
Changyou.com ltd
Type
Public
Traded as NASDAQ: CYOU
Genre massively multiplayer online games
Predecessor An online games unit of Sohu
Founded August 6, 2007 (2007-08-06)
Website changyou.com

Changyou.com ltd operates online games, primarily massively multiplayer online games, in China. Originally an internal division of Chinese Internet company Sohu, Changyou was spun off and went public in 2009. The company claims it was operating independently of Sohu as early as 2007.

Some of its games derive revenue from the sale of virtual goods, and many are licensed rather than developed in-house. Such deals have helped its roster of MMORPGs swell from two in 2009 to nearly a dozen as of 2014.

C. 2009, its most popular game may have been the MMO Tian Long Ba Bu (Chinese: 天龙八部), which translated means "Novel of Eight Demigods". Some games in its portfolio are available to play outside of China in countries including Malaysia, Taiwan, Thailand, the United States, and Vietnam.

In 2011, the company purchased nearly 70% of a browser games maker, 7Road.


Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2019 2020-03-09 1.11 1.10
Q3 2019 2019-11-04 0.59 0.64
Q2 2019 2019-08-05 0.27 0.88
Q1 2019 2019-04-29 0.69 0.69
Q4 2018 2019-02-01 0.52 0.19
Q3 2018 2018-11-05 1.01 1.03

Ratings

2016-04-26 Reiterated Rating Brean Capital Hold
2016-03-13 Reiterated Rating Summit Research Buy to Buy $26.00
2016-02-04 Downgrade Credit Suisse Outperform to Neutral $25.00 to $17.00
2016-02-04 Downgrade Credit Suisse Group AG Outperform to Neutral $25.00 to $17.00
2015-11-30 Downgrade Goldman Sachs Neutral to Sell $21.00 to $19.00
2015-11-30 Downgrade Goldman Sachs Group Inc. Neutral to Sell $21.00 to $19.00
2015-10-27 Reiterated Rating Brean Capital Hold
2015-10-19 Lower Price Target Macquarie Neutral $32.00 to $20.00
2015-10-08 Lower Price Target Barclays Underweight $26.00 to $18.00
2015-10-08 Lower Price Target Barclays PLC Underweight $26.00 to $18.00
2015-07-29 Downgrade Summit Research Buy to Hold $28.00 to $26.00
2015-07-10 Reiterated Rating Summit Research Buy $34.00 to $28.00
2015-04-29 Reiterated Rating Brean Capital Hold
2015-04-20 Initiated Coverage Summit Research Buy $32.00
2015-02-11 Reiterated Rating Brean Capital Hold
2015-01-29 Upgrade HSBC Underweight to Overweight $20.00 to $35.00
2015-01-20 Upgrade Credit Suisse Neutral to Outperform
2014-11-06 Reiterated Rating Macquarie Neutral $23.00 to $22.00
2014-10-29 Downgrade Barclays Equal Weight to Underweight $25.00 to $19.00
2014-07-30 Reiterated Rating Macquarie Neutral $27.00 to $23.00
2014-07-24 Initiated Coverage Citigroup Inc. Sell $23.40
2014-04-28 Reiterated Rating Morgan Stanley Underweight $26.00
2014-03-13 Initiated Coverage Credit Suisse Neutral $30.00
2014-03-12 Initiated Coverage BNP Paribas Reduce
2014-02-11 Downgrade HSBC Neutral to Underweight
2014-02-10 Downgrade Morgan Stanley Equal Weight to Underweight $40.00 to $26.00
2014-01-17 Downgrade Credit Suisse Outperform to Neutral
2013-10-30 Downgrade Citigroup Inc. Buy to Neutral $39.20 to $29.50
2013-10-29 Downgrade Macquarie Outperform to Neutral
2013-10-29 Downgrade Barclays Overweight to Equal Weight $44.00 to $32.00
2013-10-29 Downgrade Brean Capital Buy to Hold
2013-10-28 Reiterated Rating Morgan Stanley Overweight $44.00 to $40.00
2013-09-26 Initiated Coverage Credit Suisse Outperform
2010-02-01 Upgrade Brean Murray Hold to Buy $39
2009-10-26 Downgrade Brean Murray Buy to Hold
2009-09-10 Initiated Piper Jaffray Overweight $44
2009-07-23 Downgrade Susquehanna Financial Positive to Neutral
2009-06-08 Initiated Brean Murray Buy $47
2009-05-13 Initiated Susquehanna Financial Positive
2009-05-11 Initiated Pali Research Neutral
2016-04-26 Reiterated Rating Brean Capital Hold
2016-03-13 Reiterated Rating Summit Research Buy to Buy $26.00
2016-02-04 Downgrade Credit Suisse Outperform to Neutral $25.00 to $17.00
2016-02-04 Downgrade Credit Suisse Group AG Outperform to Neutral $25.00 to $17.00
2015-11-30 Downgrade Goldman Sachs Neutral to Sell $21.00 to $19.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks